Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ryman Healthcare's Enterprise Value is $2,220.0 Mil.
Ryman Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $-32.0 Mil. Therefore, Ryman Healthcare's EV-to-EBIT ratio for today is -69.35.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ryman Healthcare's Enterprise Value is $2,220.0 Mil.
Ryman Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-3.0 Mil. Therefore, Ryman Healthcare's EV-to-EBITDA ratio for today is -740.51.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ryman Healthcare's Enterprise Value is $2,220.0 Mil.
Ryman Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $425.8 Mil. Therefore, Ryman Healthcare's EV-to-Revenue ratio for today is 5.21.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ryman Healthcare's Enterprise Value is $2,220.0 Mil.
Ryman Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $183.0 Mil. Therefore, Ryman Healthcare's EV-to-FCF ratio for today is 12.13.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ryman Healthcare (OTCPK:RYHTY) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $-32.0 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-3.0 Mil.
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $425.8 Mil.
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2025 was $249.0 Mil.
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ryman Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $183.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ryman Healthcare Enterprise Value Related Terms
Ryman Healthcare Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ryman Healthcare's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYHTY vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Ryman Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryman Healthcare Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ryman Healthcare's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ryman Healthcare's Enterprise Value for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of $2,220.0 Mil mean?
Ryman Healthcare (RYHTY) has a Enterprise Value of $2,220.0 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ryman Healthcare and its competitors.
Is Ryman Healthcare's Enterprise Value too high?
Ryman Healthcare's current Enterprise Value is $2,220.0 Mil. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Enterprise Value compare to HCA and THC?
Ryman Healthcare's Enterprise Value of $2,220.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ryman Healthcare and its competitors. Ryman Healthcare's current Enterprise Value is $2,220.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Enterprise Value of $2,220.0 Mil. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current Enterprise Value is $2,220.0 Mil. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Enterprise Value is $2,220.0 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ryman Healthcare (RYHTY) Overvalued in 2026?
Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued.
The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.
Key valuation signals for RYHTY:
Enterprise Value: $2,220.0 Mil
GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score
Get the complete analysis for RYHTY
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYHTY has been successfully added to your 
